John M. Reher
Gründer bei Brain Trust Accelerator Fund
Profil
John M.
Reher is the founder of Accelerate Brain Cancer Cure, Inc. (founded in 2001) and Brain Trust Accelerator Fund (founded in 2006).
He holds the title of President & Executive Director at Accelerate Brain Cancer Cure, Inc. and Managing Director at Brain Trust Accelerator Fund.
Mr. Reher is also the founder of Medicus Venture Partners.
Mr. Reher's current job(s) include Chairman at NeuroTherapia, Inc. (since 2020), Director at BrainScope Co., Inc., Director at Brain Trust Accelerator Fund II LP, and Director at Chase Therapeutics Corp.Mr. Reher's former job(s) include Director at Satoris, Inc., Director at Chase Pharmaceuticals Corp., Principal at Genentech, Inc. (from 1982 to 1988), Principal at Nektar Therapeutics, Principal at Alere San Diego, Inc., Principal at Tularik, Inc., and Principal at G.D.
Searle & Co., Inc. (from 1974 to 1981).
Mr. Reher's education history includes an undergraduate degree from Benedictine University and a graduate degree from Northwestern University.
Aktive Positionen von John M. Reher
| Unternehmen | Position | Beginn |
|---|---|---|
Brain Trust Accelerator Fund
 Brain Trust Accelerator Fund Investment ManagersFinance Brain Trust Accelerator Fund (Brain Trust Accelerator) is a venture capital firm founded in 2006 by John M. Reher. The firm is headquartered in Burlingame, California. | Gründer | 01.01.2006 |
BrainScope Co., Inc.
 BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | - |
Brain Trust Accelerator Fund II LP
 Brain Trust Accelerator Fund II LP Investment ManagersFinance Brain Trust Accelerator Fund II LP invests in companies located in the United States. The fund targets companies operating in the fields of diagnosis and treatment of brain related diseases. It provides financing for early stage capital requirements. | Direktor/Vorstandsmitglied | - |
Chase Therapeutics Corp.
 Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | - |
NeuroTherapia, Inc.
 NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Vorsitzender | 22.09.2020 |
Ehemalige bekannte Positionen von John M. Reher
| Unternehmen | Position | Ende |
|---|---|---|
Accelerate Brain Cancer Cure, Inc.
 Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Accelerate Brain Cancer Cure, Inc. drives cutting-edge research and treatments for brain tumors. The firm specializes in venture philanthropy, brain cancer research and brain tumor research. The company was founded by Stacey Case, Stephen M. Case and Jean Case in 2001 and is headquartered in | Gründer | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31.12.1988 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Corporate Officer/Principal | 01.01.1981 |
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von John M. Reher
| Benedictine University | Undergraduate Degree |
| Northwestern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
Satoris, Inc.
 Satoris, Inc. Miscellaneous Commercial ServicesCommercial Services Satoris, Inc. develops tests for neurological diseases. It develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy. The company was founded in 2003 by Tony Wyss-Coray and Sandip Ray and is headquartered in Menlo Park, CA. | Commercial Services |
BrainScope Co., Inc.
BrainScope Co., Inc. Medical SpecialtiesHealth Technology BrainScope Co., Inc. operates as a medical neurotechnology company which develops non-invasive tools. The firm focuses on optimizing analysis of brain electrical signals to enhance detection and assessment of changes in brain function. The company was founded by Elvir Causevic in 1990 and is headquartered in Bethesda, MD. | Health Technology |
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Medicus Venture Partners
 Medicus Venture Partners Investment ManagersFinance Medicus Venture Partners (MVP) is a venture capital firm located in Saratoga, California. | Finance |
G.D. Searle & Co., Inc.
G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | Process Industries |
Accelerate Brain Cancer Cure, Inc.
Accelerate Brain Cancer Cure, Inc. Miscellaneous Commercial ServicesCommercial Services Accelerate Brain Cancer Cure, Inc. drives cutting-edge research and treatments for brain tumors. The firm specializes in venture philanthropy, brain cancer research and brain tumor research. The company was founded by Stacey Case, Stephen M. Case and Jean Case in 2001 and is headquartered in | Commercial Services |
Brain Trust Accelerator Fund
Brain Trust Accelerator Fund Investment ManagersFinance Brain Trust Accelerator Fund (Brain Trust Accelerator) is a venture capital firm founded in 2006 by John M. Reher. The firm is headquartered in Burlingame, California. | Finance |
Brain Trust Accelerator Fund II LP
Brain Trust Accelerator Fund II LP Investment ManagersFinance Brain Trust Accelerator Fund II LP invests in companies located in the United States. The fund targets companies operating in the fields of diagnosis and treatment of brain related diseases. It provides financing for early stage capital requirements. | Finance |
NeuroTherapia, Inc.
NeuroTherapia, Inc. Pharmaceuticals: MajorHealth Technology NeuroTherapia, Inc. discovers and develops new therapies for diseases with an underlying component of neuroinflammation. The company was founded by Mohamed Naguib Attala and Joseph F. Foss in 2015 and is headquartered in Cleveland, OH. | Health Technology |
Chase Therapeutics Corp.
Chase Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Chase Therapeutics Corp. operates as healthcare company. The company was founded in 2017 and is headquartered in Washington, DC. | Health Technology |
